Wu S, Pirola C J, Green J, Yamaguchi D T, Okano K, Jueppner H, Forrester J S, Fagin J A, Clemens T L
Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Endocrinology. 1993 Dec;133(6):2437-44. doi: 10.1210/endo.133.6.8243262.
N-Terminal analogs of PTH-related protein (PTHrP) and PTH bind to a common receptor and exhibit similar biological properties. However, recent studies suggest that certain midregion and C-terminal PTHrP peptides have activities distinct from those of PTH in the placenta and in osteoclasts, respectively. In this study we determined the biological activities of full-length recombinant PTHrP-(1-141) and several synthetic N-terminal, midregion, and C-terminal PTHrP fragments in two PTHrP-producing cell types. Peptides were tested for their ability to stimulate cAMP production and raise intracellular free calcium ([Ca2+]i) in primary rat aortic smooth muscle cells (VSMC) and UMR-106 rat osteoblast-like (UMR) cells. In UMR cells PTHrP-(1-34)NH2, PTHrP-(1-141), and bovine PTH-(1-34) all increased cAMP (approximately 50 fold) and [Ca2+]i (180 nM). By contrast, in VSMC, these N-terminal peptides increased cAMP (3-fold) but had no detectable effect on [Ca2+]i. PTHrP-(1-34) and PTHrP-(1-141) significantly blunted the angiotensin II-induced rise in cAMP (but not the calcium signal) consistent with the concept that PTHrP opposes angiotensin II activity in VSMC. PTHrP-(67-86)NH2, PTHrP-(107-138)NH2, and PTHrP-(107-111)NH2 had no effect on either cAMP or [Ca2+]i in either cell type. VSMC and UMR-106 cells both expressed a 2.5-kilobase PTH/PTHrP receptor messenger RNA (mRNA) transcript. However, high affinity specific binding of 125I-labeled [Tyr36] PTHrP-(1-36)NH2 was detected in UMR cells but not in VSMC. We conclude that the PTH-like, N terminus of the PTHrP molecule is critical in induction of cAMP and [Ca2+]i pathways in UMR cells, and for cAMP stimulation in VSMC. In addition, PTHrP, like other established vasodilators, signals in VSMC mainly (if not exclusively) by increasing the production of cAMP.
甲状旁腺激素相关蛋白(PTHrP)的N端类似物与甲状旁腺激素(PTH)结合于共同受体,并表现出相似的生物学特性。然而,最近的研究表明,某些PTHrP的中部和C端肽段在胎盘和破骨细胞中分别具有与PTH不同的活性。在本研究中,我们测定了全长重组PTHrP-(1-141)以及几种合成的PTHrP N端、中部和C端片段在两种产生PTHrP的细胞类型中的生物学活性。检测了这些肽段刺激原代大鼠主动脉平滑肌细胞(VSMC)和UMR-106大鼠成骨样细胞(UMR)中cAMP生成及提高细胞内游离钙([Ca2+]i)的能力。在UMR细胞中,PTHrP-(1-34)NH2、PTHrP-(1-141)和牛PTH-(1-34)均使cAMP增加(约50倍)和[Ca2+]i增加(180 nM)。相比之下,在VSMC中,这些N端肽段使cAMP增加(3倍),但对[Ca2+]i无明显影响。PTHrP-(1-34)和PTHrP-(1-141)显著减弱血管紧张素II诱导的cAMP升高(但不影响钙信号),这与PTHrP在VSMC中对抗血管紧张素II活性的概念一致。PTHrP-(67-86)NH2、PTHrP-(107-138)NH2和PTHrP-(107-111)NH2对两种细胞类型中的cAMP或[Ca2+]i均无影响。VSMC和UMR-106细胞均表达2.5千碱基的PTH/PTHrP受体信使核糖核酸(mRNA)转录本。然而,在UMR细胞中检测到125I标记的[Tyr36] PTHrP-(1-36)NH2的高亲和力特异性结合,而在VSMC中未检测到。我们得出结论,PTHrP分子的PTH样N端对于诱导UMR细胞中的cAMP和[Ca2+]i途径以及VSMC中的cAMP刺激至关重要。此外,PTHrP与其他已确定的血管舒张剂一样,在VSMC中主要(如果不是唯一)通过增加cAMP的产生来传递信号。